Latest Health News
U.S. Officially Withdraws from World Health Organization
The United States has completed its withdrawal from the WHO after a one-year notice, citing the organization's mishandling of the COVID-19 pandemic and refusal to pay $278 million in dues. The move, initiated by President Trump, ends a 77-year partnership and prompts CDC to cease communications with WHO.
WHO faces budget crisis, staff cuts, and discussions at February board meeting.
WHO Faces Budget Crisis After U.S. Exit
The U.S. departure, its largest funder at 18% of budget, forces WHO to halve management team, cut programs, and reduce staff by 25%. Experts warn of weakened global health threat detection and response.
Director-General Tedros urges U.S. reconsideration.
Legal Experts Question U.S. WHO Withdrawal Compliance
Critics argue the exit violates U.S. law requiring payment of arrears before departure, though Trump likely evades it. State Department halts all future funding, blaming WHO for trillions in pandemic costs.
Global health leaders like Bill Gates see no short-term rejoin.
MD Anderson Cancer Vaccine Shows Promise for Lynch Syndrome
Phase Ib/II trial of NOUS-209 immune vaccine offers potential cancer prevention for high-risk Lynch syndrome patients. Led by Eduardo Vilar-Sanchez, it intercepts cancer development early.
Highlights immune-based preventive strategies.
Novel Immunotherapy Overcomes Cancer Treatment Resistance
Phase I trial of linavonkibart (SRK-181) targets TGF-beta1, aiding resistance to anti-PD-1 therapies in multiple cancers. Led by Timothy Yap at MD Anderson, it marks a breakthrough after prior failures.
Published in Nature Medicine.
Engineered Nanobodies Boost Respiratory Virus Defenses
Preclinical study shows bispecific nanobodies enhance mucosal protection against influenza and reduce SARS-CoV-2 transmission. Multi-institutional research published in Nature Nanotechnology.
Improves respiratory tract defenses.
Gene Therapy Advances for Rare Pediatric Epilepsy
UVA Health researcher Manoj Patel develops base editing gene therapy for SCN8A-related developmental epileptic encephalopathy. Aims for one-time cure by correcting genetic sodium channel variants causing seizures.
Potential model for other genetic epilepsies.
Pancreatic Cancer Research Breakthrough Reported
Medical college in Houston announces frontline advances in pancreatic cancer fight. ABC News highlights ongoing research efforts as of January 22, 2026.
Focuses on improving outcomes for this deadly disease.
Tampa General Leads Myeloid Disorders Research
Dr. Gustavo Rivero heads translational research on myeloid disorders, including leukemia. Published January 22, 2026, emphasizes clinical advancements.
Internationally recognized work at Tampa General Hospital.
Funding Restored for Peripheral Neuropathy Research
Congressional Directed Medical Research Program rises to $1.27 billion in 2026, boosting neuropathy studies. Increase from $650 million in 2025 supports critical health research.
Enhances funding for multiple conditions.
Healthcare Trends for 2026: AI and Life Sciences Surge
AI adoption grows in diagnosis, admin, and surgery; life sciences advance in genomics, CRISPR, and mRNA cancer vaccines. Federal pushes accelerate tech in healthcare.
Biotech funding booms.
AMA Launches ACCESS Model for Chronic Care
Portal opens for physicians to join Advancing Chronic Care with Effective, Scalable Solutions model. National advocacy update dated January 23, 2026.
Aims to improve chronic disease management.